No major breakthrough in pharma reform talks. Patient representation in limbo

EU PERSPECTIVES - The second trilogue on the EU pharmaceutical package brought little political progress this week. Negotiators deferred key elements of the reform for further technical work. Among them was patient representation at the European Medicines Agency (EMA). This chapter will return to the table at the next round in November. Read more

Patients still waiting and so is Europe's pharma reform / Photo Unsplash